Background Information on mitoxantrone pharmacokinetics in children is lacking and reduced dosing regimens applied to infants are supported by limited scientific rationale. The current study characterized mitoxantrone pharmacokinetics in a childhood acute myeloid leukaemia patient population and provides a data‐informed assessment of dosing.
Andrew M. Brandon +13 more
wiley +1 more source
Integrated analysis of therapeutic strategies and prognostic factors in advanced lung adenocarcinoma: Retrospective study with emphasis on gene assays, multimodality treatment approaches and predictive machine learning models. [PDF]
You S, Chen SW, Chen I, Chen WT.
europepmc +1 more source
While providing potentially life‐saving cardiorespiratory support for critically ill patients, extracorporeal membrane oxygenation (ECMO) may detrimentally affect pharmacokinetic (PK) performance and concurrent drug efficacy and safety. We describe a patient with Pneumocystis jirovecii pneumonia (PJP) in the context of acquired immunodeficiency ...
Tom C. Zwart +7 more
wiley +1 more source
IL‑37/IL‑1R8 blocks keratinocyte acantholysis via suppressing ADAM17/EGFR. [PDF]
Hu F +6 more
europepmc +1 more source
Abstract Aim Tacrolimus monitoring is generally performed in whole blood (WB). Most (>85%) of circulating tacrolimus is bound to red blood cells. During pregnancy, WB monitoring might be suboptimal because of physiological changes including increased plasma volume and decreased haematocrit.
Jildau R. Meinderts +7 more
wiley +1 more source
Analysis of EGFR signaling pathway; miRNAs and inflammatory biomarkers in a high-risk oral cancer population in Pakistan - An exploratory study. [PDF]
Anwar N +7 more
europepmc +1 more source
Targeting tumor suppressor gene co-mutations in EGFR-mutant nonsmall cell lung cancer: How ACROSS2 sharpens the case for early intensification. [PDF]
Gunturu KS, Khan H, de Lima Lopes G.
europepmc +1 more source
Prediction of estimated glomerular filtration rate slope and kidney prognosis of patients with chronic kidney disease. [PDF]
Nagasu H +8 more
europepmc +1 more source
Germ-line exon 21 EGFR V831H mutation in advanced NSCLC resistance to almonertinib: a case report. [PDF]
Cai D, Lou J, Zhu Y, Wang Y.
europepmc +1 more source

